Cubist Systematic Strategies, LLC Geron Corp Transaction History

Cubist Systematic Strategies, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $309,967 - $609,306	177,124 New	177,124 $584,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $218,644 - $339,883	103,623 New	103,623 $219,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $42,140 - $66,952	19,692 Added 28.42%	88,982 $193,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $5,704 - $6,800	-2,810 Reduced 3.9%	69,290 $167,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $120,407 - $211,974	72,100 New	72,100 $169,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $191,067 - $308,795	-192,997 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $162,256 - $228,754	132,997 Added 221.66%	192,997 $235,000
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $95,880 - $119,850	-79,900 Reduced 57.11%	60,000 $82,000
Q2 2021 Aug 16, 2021	BUY	$1.25 - $1.83 $152,208 - $222,833	121,767 Added 671.52%	139,900 $197,000
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $20,082 - $27,745	13,212 Added 268.48%	18,133 $29,000
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $21,876 - $28,933	-14,114 Reduced 74.15%	4,921 $8,000
Q3 2020 Nov 16, 2020	SELL	$1.59 - $2.19 $29,201 - $40,221	-18,366 Reduced 49.11%	19,035 $33,000
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $39,271 - $81,534	37,401 New	37,401 $82,000
Q2 2019 Aug 14, 2019	SELL	$1.37 - $2.02 $66,728 - $98,388	-48,707 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.01 - $1.83 $49,194 - $89,133	48,707 New	48,707 $81,000

276

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.08B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.